Amedeo Smart

Free Medical Literature Service




  Free Subscription


3 Am J Respir Crit Care Med
1 Ann Intern Med
1 Antiviral Res
2 Br J Anaesth
12 Clin Infect Dis
5 Emerg Infect Dis
3 Infect Control Hosp Epidemiol
2 Int J Infect Dis
5 J Infect
12 J Med Virol
1 J Travel Med
2 J Virol
3 Lancet
6 Lancet Infect Dis
3 MMWR Morb Mortal Wkly Rep
4 N Engl J Med
2 Nature
2 Radiologia (Engl Ed)
1 Radiology
2 Science
1 Travel Med Infect Dis

    Am J Respir Crit Care Med

  1. Erratum: Comparison of 6-Month Outcomes of Survivors of COVID-19 versus Non-COVID-19 Critical Illness.
    Am J Respir Crit Care Med. 2022;206:653.
    >> Share

  2. SOOKAROMDEE P, Wiwanitkit V
    Polymorphisms and Severity of COVID-19.
    Am J Respir Crit Care Med. 2022 Aug 30. doi: 10.1164/rccm.202208-1494.
    >> Share

  3. WAN ES, Verma A, Minnier J, Iyengar S, et al
    Reply to: Polymorphisms and Severity of COVID-19.
    Am J Respir Crit Care Med. 2022 Aug 30. doi: 10.1164/rccm.202208-1611.
    >> Share

    Ann Intern Med

  4. The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19.
    Ann Intern Med. 2022 Aug 30. doi: 10.7326/M22-0924.
    >> Share

    Antiviral Res

  5. DEMAREST JF, Kienle M, Boytz R, Ayres M, et al
    Brequinar and dipyridamole in combination exhibits synergistic antiviral activity against SARS-CoV-2 in vitro: Rationale for a host-acting antiviral treatment strategy for COVID-19.
    Antiviral Res. 2022 Aug 27:105403. doi: 10.1016/j.antiviral.2022.105403.
    >> Share


  6. MATTHEWS AA, Danaei G, Islam N, Kurth T, et al
    Target trial emulation: applying principles of randomised trials to observational studies.
    BMJ. 2022;378:e071108.
    >> Share

    Br J Anaesth

  7. HEERDT PM, Shelley B, Singh I
    Corrigendum to 'Impaired systemic oxygen extraction long after mild COVID-19: potential perioperative implications' (Br J Anaesth 2022; 128: e246-9).
    Br J Anaesth. 2022 Aug 27. pii: S0007-0912(22)00397.
    >> Share

  8. COHEN JB, Patel SY
    Parallels between our response to COVID-19 and approach to patient safety.
    Br J Anaesth. 2022 Aug 1. pii: S0007-0912(22)00386.
    >> Share

    Clin Infect Dis

  9. SWANK Z, Senussi Y, Manickas-Hill Z, Yu XG, et al
    Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae.
    Clin Infect Dis. 2022 Sep 2. pii: 6686531. doi: 10.1093.
    >> Share

  10. WIRTH KE, Edwards JK, Feinstein L, Breskin A, et al
    When emulating a trial, do as the trialists do: Missteps in estimating relative effectiveness of a SARS-CoV-2 vaccine booster dose.
    Clin Infect Dis. 2022 Aug 30. pii: 6679241. doi: 10.1093.
    >> Share

  11. HARRIGAN SP, Wilton J, Chong M, Abdia Y, et al
    Clinical severity of Omicron SARS-CoV-2 variant relative to Delta in British Columbia, Canada: A retrospective analysis of whole genome sequenced cases.
    Clin Infect Dis. 2022 Aug 30. pii: 6679248. doi: 10.1093.
    >> Share

  12. YIP TCF, Lui GCY, Lai MSM, Wong VWS, et al
    Impact of the use of oral antiviral agents on the risk of hospitalization in community COVID-19 patients.
    Clin Infect Dis. 2022 Aug 29. pii: 6678124. doi: 10.1093.
    >> Share

  13. LOHSE ZM, Shapiro JJ, Lednicky JA, Cash MN, et al
    Persistence of SARS-CoV-2 omicron variant in children and utility of rapid antigen testing as an indicator of culturable virus.
    Clin Infect Dis. 2022 Aug 27. pii: 6677545. doi: 10.1093.
    >> Share

  14. KLOMPAS M, Baker MA, Rhee C
    Coronavirus Disease 2019's Challenges to Infection Control Dogma Regarding Respiratory Virus Transmission.
    Clin Infect Dis. 2022;75:e102-e104.
    >> Share

  15. KLEIN B, Harris DA
    Examining the Robustness of 3 Versus 6 Feet of Physical Distancing in Schools: A Reanalysis of van den Berg et al.
    Clin Infect Dis. 2022;75:e310-e311.
    >> Share

  16. GANDHI M
    Immunity Against the Omicron Variant from Vaccination, Recovery or Both.
    Clin Infect Dis. 2022 Mar 2. pii: 6540839. doi: 10.1093.
    >> Share

  17. FISHER BT, Boge CLK, Xiao R, Shuster S, et al
    Multicenter Prospective Study of Biomarkers for Diagnosis of Invasive Candidiasis in Children and Adolescents.
    Clin Infect Dis. 2022;75:248-259.
    >> Share

  18. SPAULDING AC, Zawitz C
    Vaccination in Prisons and Jails: Corrections Needed in Future Plans.
    Clin Infect Dis. 2022 Jan 27. pii: 6515673. doi: 10.1093/cid/ciab1031.
    >> Share

    Are Patients Exhibiting Post-Coronavirus Disease (COVID) Symptoms at 12 months the Same at 5 or 9 Months? The Fluctuating Nature of Post-COVID.
    Clin Infect Dis. 2022;75:e1208.
    >> Share

  20. REDDY KP, Kruse GR, Lee S, Shuter J, et al
    Tobacco Use and Treatment of Tobacco Dependence Among People with HIV: A Practical Guide for Clinicians.
    Clin Infect Dis. 2022 Jan 3. pii: 6494528. doi: 10.1093/cid/ciab1069.
    >> Share

    Emerg Infect Dis

  21. SIM JY, Wu PS, Cheng CF, Chao YC, et al
    Effectiveness of Booster and Influenza Vaccines against COVID-19 among Healthcare Workers, Taiwan.
    Emerg Infect Dis. 2022;28.
    >> Share

  22. LOPEZ-MUNOZ I, Torrella A, Lopez-Quilez O, Castillo-Zuza A, et al
    SARS-CoV-2 Secondary Attack Rates in Vaccinated and Unvaccinated Household Contacts during Replacement of Delta with Omicron Variant, Spain.
    Emerg Infect Dis. 2022;28.
    >> Share

  23. WOLFENSBERGER A, Kufner V, Zaheri M, Zeeb M, et al
    Nosocomial COVID-19 Incidence and Secondary Attack Rates among Patients of Tertiary Care Center, Zurich, Switzerland.
    Emerg Infect Dis. 2022;28.
    >> Share

  24. CHAN DPC, Wong NS, Wong BCK, Chan JMC, et al
    Three-Dose Primary Series of Inactivated COVID-19 Vaccine for Persons Living with HIV, Hong Kong.
    Emerg Infect Dis. 2022;28.
    >> Share

  25. KEYEL AC, Russell A, Plitnick J, Rowlands JV, et al
    SARS-CoV-2 Vaccine Breakthrough by Omicron and Delta Variants, New York, USA.
    Emerg Infect Dis. 2022;28.
    >> Share

    Infect Control Hosp Epidemiol

  26. DE ST MAURICE A, Parti U, Anikst VE, Harper T, et al
    Clinical, microbiological, and genomic characteristics of clade-III Candida auris colonization and infection in southern California, 2019-2022.
    Infect Control Hosp Epidemiol. 2022 Sep 2:1-9. doi: 10.1017/ice.2022.
    >> Share

  27. JONES K, Hadley E, Preiss S, Lofgren ET, et al
    Estimate of undetected severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in acute-care hospital settings using an individual-based microsimulation model.
    Infect Control Hosp Epidemiol. 2022 Sep 1:1-10. doi: 10.1017/ice.2022.
    >> Share

  28. BEN-ADERET MA, Madhusudhan MS, Haroun P, Almario MJP, et al
    Characterizing the relationship between coronavirus disease 2019 (COVID-19) and central-line-associated bloodstream infection (CLABSI) and assessing the impact of a nursing-focused CLABSI reduction intervention during the COVID-19 pandemic.
    Infect Control Hosp Epidemiol. 2022 Aug 31:1-8. doi: 10.1017/ice.2022.
    >> Share

    Int J Infect Dis

  29. BRUNNER WM, Freilich D, Victory J, Krupa N, et al
    Comparison of Antibody Response Durability of mRNA-1273, BNT162b2, and Ad26.COV2.S SARS-CoV-2 Vaccines in Healthcare Workers.
    Int J Infect Dis. 2022 Aug 28. pii: S1201-9712(22)00492.
    >> Share

  30. WAITS A, Chen JY, Cheng WH, Yeh JI, et al
    Safety and Immunogenicity of MVC-COV1901 Vaccine in Older Adults: Phase 2 Randomized Dose-Comparison Trial.
    Int J Infect Dis. 2022 Aug 29. pii: S1201-9712(22)00491.
    >> Share

    J Infect

  31. LINA L, Zhendong G, Sevalie S, Fangfang Z, et al
    Comparison of the amount of SARS-CoV-2 exhaled by Delta and Omicron patients.
    J Infect. 2022 Aug 28. pii: S0163-4453(22)00512.
    >> Share

  32. KIM SH, Kyu Cho H, Jeon CH, Sung Ock H, et al
    Diagnostic value of serum KL-6 and IL-6 levels in critically ill patients with COVID-19-associated pneumonia.
    J Infect. 2022 Aug 27. pii: S0163-4453(22)00477.
    >> Share

  33. WANG Y, Zheng J, Zhu K, Wang B, et al
    The effect of tixagevimab-cilgavimab on clinical outcomes in patients with COVID-19: A systematic review with meta-analysis.
    J Infect. 2022 Aug 25. pii: S0163-4453(22)00506.
    >> Share

  34. BAYHAN GI, Korkmaz IO, Seyda E, Tekeli N, et al
    Are SARS-CoV-2 viral loads in children lower than in adults?
    J Infect. 2022 Aug 24. pii: S0163-4453(22)00509.
    >> Share

  35. GIDARI A, Schiaroli E, Sabbatini S, Bastianelli S, et al
    Impact of SARS-CoV-2 Omicron Variants on Serum Neutralization in a Cohort of Healthcare Workers Vaccinated with BNT162b2.
    J Infect. 2022 Aug 25. pii: S0163-4453(22)00507.
    >> Share

    J Med Virol

  36. KAYA Y, Gulcu O, Aksakal E, Kalkan K, et al
    A Significant Predictor of In-Hospital and Long-term Mortality and Progression In COVID-19 Patients: The End-Stage Liver Disease (MELD) Score Model.
    J Med Virol. 2022 Aug 31. doi: 10.1002/jmv.28109.
    >> Share

  37. BARANOVA A, Cao H, Zhang F
    Causal Effect of COVID-19 on Alzheimer's Disease: A Mendelian Randomization Study.
    J Med Virol. 2022 Aug 30. doi: 10.1002/jmv.28107.
    >> Share

  38. GENG Y, Wang Y
    Stability and transmissibility of SARS-CoV-2 in the environment.
    J Med Virol. 2022 Aug 30. doi: 10.1002/jmv.28103.
    >> Share

  39. YAO Y, Song H, Zhang F, Liu J, et al
    Genetic predisposition to blood cell indices in relation to severe COVID-19.
    J Med Virol. 2022 Aug 29. doi: 10.1002/jmv.28104.
    >> Share

  40. COLSON P, Gautret P, Delerce J, Chaudet H, et al
    The emergence, spread and vanishing of a French SARS-CoV-2 variant exemplifies the fate of RNA virus epidemics and obeys the Mistigri rule.
    J Med Virol. 2022 Aug 28. doi: 10.1002/jmv.28102.
    >> Share

  41. LIU S, Cai J, Li Y, Ying L, et al
    Outbreak of acute respiratory disease caused by human adenovirus type 7 and Human Coronavirus-229E in Zhejiang Province, China.
    J Med Virol. 2022 Aug 28. doi: 10.1002/jmv.28101.
    >> Share

  42. XIE J, Klemsz MJ, Kacena MA, Sandusky G, et al
    Inhibition of MEK signaling prevents SARS-CoV2-induced lung damage and improves the survival of infected mice.
    J Med Virol. 2022 Aug 28. doi: 10.1002/jmv.28094.
    >> Share

  43. GHANG B, Kim S, Kim J
    Autoimmune rheumatic disease after SARS-CoV-2 vaccination.
    J Med Virol. 2022 Aug 27. doi: 10.1002/jmv.28092.
    >> Share

  44. CAO H, Baranova A, Wei X, Wang C, et al
    Bidirectional causal associations between type 2 diabetes and COVID-19.
    J Med Virol. 2022 Aug 27. doi: 10.1002/jmv.28100.
    >> Share

  45. SALIMIAN J, Ahmadi A, Amani J, Olad G, et al
    Safety and Immunogenicity of a Recombinant Receptor Binding Domain-Based Protein Subunit Vaccine (Noora Vaccine) Against COVID-19 in Adults: A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial.
    J Med Virol. 2022 Aug 27. doi: 10.1002/jmv.28097.
    >> Share

  46. ALI AM, Tofiq AM, Rostam HM, Ali KM, et al
    Disease Severity and Efficacy of Homologous Vaccination Among Patients Infected with SARS-CoV-2 Delta or Omicron VOCs, Compared to Unvaccinated using Main Biomarkers.
    J Med Virol. 2022 Aug 27. doi: 10.1002/jmv.28098.
    >> Share

  47. LIU H, Chang S, Chen S, Du Y, et al
    Highly sensitive and rapid detection of SARS-CoV-2 via a portable CRISPR-Cas13a-based lateral flow assay.
    J Med Virol. 2022 Aug 27. doi: 10.1002/jmv.28096.
    >> Share

    J Travel Med

  48. HINCAPIE R, Munoz D, Ortega N, Isfeld-Kiely HK, et al
    Effect of Flight Connectivity on Introduction and Evolution of COVID-19 in Canadian Cities.
    J Travel Med. 2022 Aug 30. pii: 6679266. doi: 10.1093.
    >> Share

    J Virol

  49. ZHANG C, Cui H, Guo Z, Chen Z, et al
    SARS-CoV-2 Virus Culture, Genomic and Subgenomic RNA Load, and Rapid Antigen Test in Experimentally Infected Syrian Hamsters.
    J Virol. 2022 Aug 30:e0103422. doi: 10.1128/jvi.01034.
    >> Share

  50. FAN B, Peng Q, Song S, Shi D, et al
    Nonstructural Protein 1 of Variant PEDV Plays a Key Role in Escaping Replication Restriction by Complement C3.
    J Virol. 2022 Aug 29:e0102422. doi: 10.1128/jvi.01024.
    >> Share


  51. BARNETT ML, Waken RJ, Zheng J, Orav EJ, et al
    Changes in Health and Quality of Life in US Skilled Nursing Facilities by COVID-19 Exposure Status in 2020.
    JAMA. 2022 Aug 29. pii: 2795935. doi: 10.1001/jama.2022.15071.
    >> Share


  52. UYEKI TM, Hui DS, Zambon M, Wentworth DE, et al
    Lancet. 2022;400:693-706.
    >> Share

  53. BOLLYKY TJ, Angelino O, Wigley S, Dieleman JL, et al
    Trust made the difference for democracies in COVID-19.
    Lancet. 2022;400:657.
    >> Share

  54. MOETI M, Gao GF, Herrman H
    Global pandemic perspectives: public health, mental health, and lessons for the future.
    Lancet. 2022;400:e3-e7.
    >> Share

    Lancet Infect Dis

  55. WONG CKH, Au ICH, Lau KTK, Lau EHY, et al
    Real-world effectiveness of early molnupiravir or nirmatrelvir-ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong's omicron BA.2 wave: a retrospective cohort study.
    Lancet Infect Dis. 2022 Aug 24. pii: S1473-3099(22)00507.
    >> Share

  56. AABY P, Netea MG, Benn CS
    Beneficial non-specific effects of live vaccines against COVID-19 and other unrelated infections.
    Lancet Infect Dis. 2022 Aug 26. pii: S1473-3099(22)00498.
    >> Share

  57. GAVRIILAKI E, Kokoris S
    COVID-19 sequelae: can long-term effects be predicted?
    Lancet Infect Dis. 2022 Aug 25. pii: S1473-3099(22)00529.
    >> Share

  58. PERICO N, Cortinovis M, Suter F, Remuzzi G, et al
    Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents.
    Lancet Infect Dis. 2022 Aug 25. pii: S1473-3099(22)00433.
    >> Share

  59. DEUEL JW, Lauria E, Lovey T, Zweifel S, et al
    Persistence, prevalence, and polymorphism of sequelae after COVID-19 in unvaccinated, young adults of the Swiss Armed Forces: a longitudinal, cohort study (LoCoMo).
    Lancet Infect Dis. 2022 Aug 25. pii: S1473-3099(22)00449.
    >> Share

    Early oral antiviral use in patients hospitalised with COVID-19.
    Lancet Infect Dis. 2022 Aug 24. pii: S1473-3099(22)00522.
    >> Share

    MMWR Morb Mortal Wkly Rep

  61. LUTRICK K, Fowlkes A, Rivers P, Herder K, et al
    Parental Intentions and Perceptions Toward COVID-19 Vaccination Among Children Aged 4 Months to 4 Years - PROTECT Cohort, Four States, July 2021-May 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1109-1114.
    >> Share

  62. HAUSE AM, Marquez P, Zhang B, Myers TR, et al
    COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months-5 Years - United States, June 18, 2022-August 21, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1115-1120.
    >> Share

  63. FAST HE, Murthy BP, Zell E, Meng L, et al
    Booster COVID-19 Vaccinations Among Persons Aged >/=5 Years and Second Booster COVID-19 Vaccinations Among Persons Aged >/=50 Years - United States, August 13, 2021-August 5, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1121-1125.
    >> Share

    N Engl J Med

  64. MALATO J, Ribeiro RM, Leite PP, Casaca P, et al
    Risk of BA.5 Infection among Persons Exposed to Previous SARS-CoV-2 Variants.
    N Engl J Med. 2022 Aug 31. doi: 10.1056/NEJMc2209479.
    >> Share

    Covid-19 Vaccines - Immunity, Variants, Boosters.
    N Engl J Med. 2022 Aug 31. doi: 10.1056/NEJMra2206573.
    >> Share

  66. DUPONT SC, Galea S
    Science, Competing Values, and Trade-offs in Public Health - The Example of Covid-19 and Masking.
    N Engl J Med. 2022 Sep 3. doi: 10.1056/NEJMp2207670.
    >> Share

  67. RUBIN EJ, Baden LR, Swaminathan S, Morrissey S, et al
    Audio Interview: Covid-19 and the WHO.
    N Engl J Med. 2022;387:e24.
    >> Share


    COVID vaccines slash risk of spreading Omicron - and so does previous infection.
    Nature. 2022 Aug 26. pii: 10.1038/d41586-022-02328.
    >> Share

  69. WOODRUFF MC, Ramonell RP, Haddad NS, Anam FA, et al
    Dysregulated naive B cells and de novo autoreactivity in severe COVID-19.
    Nature. 2022 Aug 31. pii: 10.1038/s41586-022-05273.
    >> Share

    Radiologia (Engl Ed)

  70. SAEZ DE GORDOA E, Portella A, Escudero-Fernandez JM, Andreu Soriano J, et al
    Usefulness of chest X-rays for detecting COVID 19 pneumonia during the SARS-CoV-2 pandemic.
    Radiologia (Engl Ed). 2022;64:310-316.
    >> Share

  71. BARRIO PIQUERAS M, Ezponda Casajus A, Urtasun Iriarte C, Larrache Latasa J, et al
    Low-dose chest CT for preoperative screening for SARS-CoV-2 infection.
    Radiologia (Engl Ed). 2022;64:317-323.
    >> Share


  72. KANNE JP, Little BP, Schulte JJ, Haramati A, et al
    Long-Term Lung Abnormalities Associated with COVID-19 Pneumonia.
    Radiology. 2022 Aug 30:221806. doi: 10.1148/radiol.221806.
    >> Share


  73. COHEN J
    Anywhere but here.
    Science. 2022;377:805-809.
    >> Share

    The FDA and scientific priorities.
    Science. 2022;377:905.
    >> Share

    Travel Med Infect Dis

  75. SABANER E, Kolbakir F, Ercan E
    Evaluation of fatigue and sleep problems in cabin crews during the early COVID-19 pandemic period.
    Travel Med Infect Dis. 2022 Aug 24:102430. doi: 10.1016/j.tmaid.2022.102430.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016